March 27, 2010 - Volume 24 - Issue 6
pp: 789-940



Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons

Brown, Todd T; Mehta, Shruti H; Sutcliffe, Catherine; More

AIDS. 24(6):811-817, March 27, 2010.

Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression

Roberts, Lindi; Passmore, Jo-Ann S; Williamson, Carolyn; More

AIDS. 24(6):819-831, March 27, 2010.

Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease

Pinti, Marcello; Gibellini, Lara; Guaraldi, Giovanni; More

AIDS. 24(6):841-850, March 27, 2010.


Frequent hepatitis B virus rebound among HIV–hepatitis B virus-coinfected patients following antiretroviral therapy interruption

Dore, Gregory J; Soriano, Vicente; Rockstroh, Jürgen; More

AIDS. 24(6):857-865, March 27, 2010.

Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120–CD4-binding site from long-term survivors of HIV infection

Planque, Stephanie; Salas, Maria; Mitsuda, Yukie; More

AIDS. 24(6):875-884, March 27, 2010.

Concise Communication


Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy

Murphy, Robert L; Berzins, Baiba; Zala, Carlos; More

AIDS. 24(6):885-890, March 27, 2010.


Treatment with antiretroviral therapy is not associated with increased sexual risk behavior in Kenyan female sex workers

McClelland, R Scott; Graham, Susan M; Richardson, Barbra A; More

AIDS. 24(6):891-897, March 27, 2010.

CONCISE COMMUNICATION



Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients...

Nozza, Silvia; Galli, Laura; Visco, Francesca; More

AIDS. 24(6):924-928, March 27, 2010.




1 2 3 4 5